BUFFALO, NY, Oct 18, 2007.  Cleveland BioLabs, Inc. (NASDAQ: CBLI) (BOST: CBLI) today announced that it has completed Good Manufacturing Practices compliant (cGMP) manufacturing of Protectan CBLB502.

Dr. Michael Fonstein, Chief Executive Officer and President of Cleveland BioLabs, s ...

Amsterdam, The Netherlands, 17 April 2007- SynCo Bio Partners and Prosensa announce today their agreement to collaborate in the formulation and fill of RNA based therapeutics for the treatment of Duchenne Muscular Dystrophy (DMD).

Prosensa, a clinical stage biopharmaceutical company and S ...